-
Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities
Mar 10, 2025, 14:00 PM -
Precision Medicine Enabled Benefits Management for Oral Diabetes and Weight Loss Management
Mar 10, 2025, 14:00 PM -
Utilization of Overall Survival and Other Survival Endpoints in Clinical Trials for Adjuvant Therapies in Resectable Tumors
Mar 10, 2025, 14:00 PM -
Emerging Trends in List Price Adjustment Strategies Following Implementation of the Inflation Reduction Act
Mar 10, 2025, 14:00 PM -
Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)
Mar 10, 2025, 14:00 PM -
Burden of Illness in CIDP: Results of a Multinational Real-World Survey
Mar 10, 2025, 14:00 PM -
Predictive Modeling for Designing a Personalized Statin Therapy: Optimizing Treatment Efficacy in Cardiovascular Disease Prevention
Mar 10, 2025, 14:00 PM -
Assessing the Impact of Digital Ecosystem Engagement on Outcomes in Sickle Cell Disease (SCD) Patients
Mar 10, 2025, 14:00 PM -
Progression-Free Survival and Objective Response Rates As Surrogate Endpoints for Overall Survival Among Patients With ROS1+ Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving ROS1 Tyrosine Kinase Inhibitors
Mar 10, 2025, 14:00 PM -
The Relationship Between Progression-Free Survival and Overall Survival in Relapsed/Refractory Multiple Myeloma: A Meta-Regression of Clinical Trial Data
Mar 10, 2025, 14:00 PM -
Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China
Mar 10, 2025, 14:00 PM -
Leveraging Artificial Intelligence for Thematic Analysis of Qualitative Transcripts: A Feasibility Study in Insurance Payer Interviews
Mar 10, 2025, 14:00 PM -
The Association Between COVID-19 Vaccination and Health-Related Quality of Life and Work Productivity: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
The Impact of the Inflation Reduction Act on Rare Diseases and Orphan Drugs
Mar 10, 2025, 14:00 PM -
Real-time Predictions of Maternity Episode Expenses Using Machine Learning
Mar 10, 2025, 14:00 PM -
Responses of Pharmaceutical Companies to Literature Review Inquiries from a Regulatory Authority: A Retrospective Analysis.
Mar 10, 2025, 14:00 PM -
Shifting Landscapes: Rising Trends in Breast and Colon Cancer Screenings and Diagnoses
Mar 10, 2025, 14:00 PM -
Racial Disparities and the Impact of Access Restrictions to Apixaban in Part D
Mar 10, 2025, 14:00 PM -
Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities
Mar 10, 2025, 14:00 PM -
Too Many PICOS for Joint Clinical Assessments (JCA)? How To Adapt The Systematic Literature Reviews for Achieving Desired Outcomes
Mar 10, 2025, 14:00 PM
